Literature DB >> 8587603

Vasoactive effects of fibrinogen on saphenous vein.

R C Hicks1, J Golledge, R Mir-Hasseine, J T Powell.   

Abstract

Normal plasma fibrinogen concentrations are critical to haemostasis. Higher fibrinogen concentrations are associated with increasing risk of atherosclerotic disease and with graft stenosis and occlusion after saphenous vein bypass surgery. Vein graft stenosis is characterized by the localized proliferation of intimal smooth muscle cells, causing narrowing of the graft with increased risk of thrombotic occlusion. In rabbit arteries, fibrinopeptide B is reported to have both vasoconstrictor and mitogenic properties. We report here that fibrinopeptides had no vasoactive effects on saphenous vein rings; however, fibrinogen (0-2 microM) affected an endothelium-dependent relaxation, followed by recontraction at higher concentrations. The fibrinogen-mediated relaxation was inhibited by K+-channel blockers and antibodies to ICAM-1. Coupled signalling pathways for the synthesis of vasoactive mediators and mitogens could underlie the association between fibrinogen and the development of vein graft pathology.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8587603     DOI: 10.1038/379818a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  7 in total

1.  Involvement of fibrinogen specific binding in erythrocyte aggregation.

Authors:  David Lominadze; William L Dean
Journal:  FEBS Lett       Date:  2002-04-24       Impact factor: 4.124

2.  Circumferential deformation and shear stress induce differential responses in saphenous vein endothelium exposed to arterial flow.

Authors:  J Golledge; R J Turner; S L Harley; D R Springall; J T Powell
Journal:  J Clin Invest       Date:  1997-06-01       Impact factor: 14.808

3.  Fibrinogen-induced increased pial venular permeability in mice.

Authors:  Nino Muradashvili; Natia Qipshidze; Charu Munjal; Srikanth Givvimani; Richard L Benton; Andrew M Roberts; Suresh C Tyagi; David Lominadze
Journal:  J Cereb Blood Flow Metab       Date:  2011-10-12       Impact factor: 6.200

Review 4.  Fibrinogen and coronary risk.

Authors:  W Koenig
Journal:  Curr Cardiol Rep       Date:  1999-07       Impact factor: 2.931

5.  Fibrinogen up-regulates the expression of monocyte chemoattractant protein 1 in human saphenous vein endothelial cells.

Authors:  S L Harley; J T Powell
Journal:  Biochem J       Date:  1999-08-01       Impact factor: 3.857

6.  Fibrinogen and left ventricular myocardial systolic function: The Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Raymond T Yan; Veronica Fernandes; Andrew T Yan; Mary Cushman; Alban Redheuil; Russell Tracy; Jens Vogel-Claussen; Hossein Bahrami; Khurram Nasir; David A Bluemke; Joao A C Lima
Journal:  Am Heart J       Date:  2010-09       Impact factor: 4.749

Review 7.  Mechanisms of fibrinogen-induced microvascular dysfunction during cardiovascular disease.

Authors:  D Lominadze; W L Dean; S C Tyagi; A M Roberts
Journal:  Acta Physiol (Oxf)       Date:  2009-09-01       Impact factor: 6.311

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.